These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 20186817

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Facial angiofibroma as an initial manifestation in multiple endocrine neoplasia type 1.
    Sakurai A, Hashizume K, Fukushima Y.
    Intern Med; 2008; 47(11):1067-8. PubMed ID: 18520124
    [No Abstract] [Full Text] [Related]

  • 9. Unilateral facial angiofibromas--a segmental form of tuberous sclerosis.
    McGrae JD, Hashimoto K.
    Br J Dermatol; 1996 Apr; 134(4):727-30. PubMed ID: 8733380
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Facial angiofibromas in a mosaic pattern tuberous sclerosis: A case report.
    Alshaiji JM, Spock CR, Connelly EA, Schachner LA.
    Dermatol Online J; 2012 Jul 15; 18(7):8. PubMed ID: 22863630
    [Abstract] [Full Text] [Related]

  • 12. Isolated and unilateral facial angiofibromas revealing a type 1 segmental postzygotic mosaicism of tuberous sclerosis complex with c.4949_4982del TSC2 mutation.
    Bessis D, Malinge MC, Girard C.
    Br J Dermatol; 2018 Jan 15; 178(1):e53-e54. PubMed ID: 29315486
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Topical rapamycin solution to treat multiple facial angiofibromas in a patient with tuberous sclerosis].
    Valerón-Almazán P, Vitiello M, Abuchar A, Kerdel FA.
    Actas Dermosifiliogr; 2012 Mar 15; 103(2):165-6. PubMed ID: 21861956
    [No Abstract] [Full Text] [Related]

  • 16. Angiofibromas with multiple epidermoid cysts in tuberous sclerosis: new mutation or post-traumatic?
    Zheng LQ, Huang Y, Han XC.
    J Cutan Pathol; 2013 May 15; 40(5):509-12. PubMed ID: 23418925
    [Abstract] [Full Text] [Related]

  • 17. Unilateral Facial Angiofibromas.
    Basu D, Kumar P, Das A.
    Skinmed; 2019 May 15; 17(1):52-53. PubMed ID: 30888949
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparative Effects of Topical 0.2% Sirolimus for Angiofibromas in Adults and Pediatric Patients with Tuberous Sclerosis Complex.
    Lee YI, Lee JH, Kim DY, Chung KY, Shin JU.
    Dermatology; 2018 May 15; 234(1-2):13-22. PubMed ID: 29925060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.